Clinical Trial Update: Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) [Phase 3]

View source ↗

Summary

A Phase 3 trial (TALC) evaluated tiotropium bromide as an alternative to increasing inhaled corticosteroid dose for patients with asthma inadequately controlled…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• tiotropium bromide (tiotropium)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-04-09